These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15226683)

  • 1. [Mechanisms of action of diacerein, the first inhibitor of interleukin-1 in osteoarthritis].
    Solignac M
    Presse Med; 2004 May; 33(9 Pt 2):S10-2. PubMed ID: 15226683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1.
    Felisaz N; Boumediene K; Ghayor C; Herrouin JF; Bogdanowicz P; Galerra P; Pujol JP
    Osteoarthritis Cartilage; 1999 May; 7(3):255-64. PubMed ID: 10329300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of diacerein on the symptoms and radiographic progression of osteoarthritis].
    Provvedini D; Cohen P
    Presse Med; 2002 Dec; 31(39 Pt 2):4S13-5. PubMed ID: 12518072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures.
    Yaron M; Shirazi I; Yaron I
    Osteoarthritis Cartilage; 1999 May; 7(3):272-80. PubMed ID: 10329302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of IL-1beta catabolic effects on cartilage: a mechanism involved on diacerein anti-OA properties.
    de Isla NG; Stoltz JF
    Biorheology; 2008; 45(3-4):433-8. PubMed ID: 18836243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhein, an active metabolite of diacerein, suppresses the interleukin-1alpha-induced proteoglycan degradation in cultured rabbit articular chondrocytes.
    Tamura T; Ohmori K
    Jpn J Pharmacol; 2001 Jan; 85(1):101-4. PubMed ID: 11243562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1beta synthesis by chondrocyte analyzed by 3D microscopy and flow cytometry: effect of Rhein.
    de Isla NG; Yang JW; Huselstein C; Muller S; Stoltz JF
    Biorheology; 2006; 43(3,4):595-601. PubMed ID: 16912431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diacerein on biosynthesis activities of chondrocytes in culture.
    Pujol JP; Felisaz N; Boumediene K; Ghayor C; Herrouin JF; Bogdanowicz P; Galera P
    Biorheology; 2000; 37(1-2):177-84. PubMed ID: 10912190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diacerein.
    Spencer CM; Wilde MI
    Drugs; 1997 Jan; 53(1):98-106; discussion 107-8. PubMed ID: 9010651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diacerein for osteoarthritis.
    Fidelix TS; Soares BG; Trevisani VF
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005117. PubMed ID: 16437519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis.
    Domagala F; Martin G; Bogdanowicz P; Ficheux H; Pujol JP
    Biorheology; 2006; 43(3,4):577-87. PubMed ID: 16912429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects.
    Dozin B; Malpeli M; Camardella L; Cancedda R; Pietrangelo A
    Matrix Biol; 2002 Aug; 21(5):449-59. PubMed ID: 12225810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disease modifying osteoarthritis drug diacerein is able to antagonize pro inflammatory state of chondrocytes under mild mechanical stimuli.
    Steinecker-Frohnwieser B; Weigl L; Kullich W; Lohberger B
    Osteoarthritis Cartilage; 2014 Jul; 22(7):1044-52. PubMed ID: 24857974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diacetylrhein, a new therapeutic approach of osteoarthritis].
    Taccoen A; Berdah L
    Rev Rhum Ed Fr; 1993 Jul; 60(6 Pt 2):83S-86S. PubMed ID: 8118457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacerein-thymol prodrug: in vivo release and pharmacological screening in experimental models of osteoarthritis in Wistar rats.
    Patil D; Dhaneshwar S; Kadam P
    Inflamm Allergy Drug Targets; 2015; 13(6):393-405. PubMed ID: 25675406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast--comparison to its effects on osteoarthritic chondrocytes.
    Alvarez-Soria MA; Herrero-Beaumont G; Sánchez-Pernaute O; Bellido M; Largo R
    Rheumatology (Oxford); 2008 May; 47(5):627-33. PubMed ID: 18375401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diacerein reduces the level of cartilage chondrocyte DNA fragmentation and death in experimental dog osteoarthritic cartilage at the same time that it inhibits caspase-3 and inducible nitric oxide synthase.
    Pelletier JP; Mineau F; Boileau C; Martel-Pelletier J
    Clin Exp Rheumatol; 2003; 21(2):171-7. PubMed ID: 12747270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the pharmacologic effect of diacerein and a selective COX-2 inhibitor in the mouse induced-granuloma model].
    Colville-Nash PR
    Presse Med; 2002 Dec; 31(39 Pt 2):4S16-7. PubMed ID: 12518073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacerein as a disease-modulating agent in osteoarthritis.
    Falgarone G; Dougados M
    Curr Rheumatol Rep; 2001 Dec; 3(6):479-83. PubMed ID: 11709109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.
    Permuy M; Guede D; López-Peña M; Muñoz F; Caeiro JR; González-Cantalapiedra A
    BMC Musculoskelet Disord; 2015 May; 16():120. PubMed ID: 25986068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.